LTD.;JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO.
发明人:
SHI, Dongfang,FU, Changjin,CHENG, Xi,ZHU, Jianghua,WEN, Jie,GU, Jie
申请号：
SG11201802010Q
公开号：
SG11201802010QA
申请日:
2016.09.08
申请国别(地区):
SG
年份:
2018
代理人:
摘要：
Provided are a compound as represented in formula (I), a pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and uses thereof. The compound as represented in formula (I) and the pharmaceutically acceptable salts thereof are used in the preparation of medicines for the treatment or prevention of hyperuricemia or gout by means of uric acid excretion.
